Objectives To determine the efficacy of wet-cupping for treating persistent nonspecific low back pain.
Inclusion criteria included: (a) lower back pain persisting for 4 weeks or more;(b) age 17–68 years; and; (c) current episode of low back pain having at least a 4-week duration. Exclusion criteria included possible spinal pathology (e.g., carcinoma), severe or progressive motor weakness or central disc prolapse, pending litigation (e.g., workplace injury), bleeding disorders (e.g., hemophilia), and current treatment with wet-cupping.
In total, 98 patients aged 17–68 years with nonspecific low back pain; 48 were randomly assigned to experimental group and 50 to the control group. Patients in the experimental group were offered to the wet-cupping service and the control group received usual care.
Main outcome measures: Three outcomes assessed at baseline and again 3 months following intervention: the McGill Present Pain Index, Oswestry Pain Disability Index, and the Medication Quantification Scale.
General information
Acronym
IRCT registration information
IRCT registration number:IRCT138707161310N1
Registration date:2008-10-21, 1387/07/30
Registration timing:registered_while_recruiting
Last update:
Update count:0
Registration date
2008-10-21, 1387/07/30
Registrant information
Name
Alireza Ahmadi
Name of organization / entity
Kermanshah University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 83 3428 2670
Email address
info-jivr@kums.ac.ir
Recruitment status
Recruitment complete
Funding source
Kermanshah University of Medical Sciences, Iran
Expected recruitment start date
2008-05-14, 1387/02/25
Expected recruitment end date
2009-05-14, 1388/02/24
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The effectiveness of wet-cupping for nonspecific low back pain
Public title
The effectiveness of wet-cupping for nonspecific low back pain in Iran: A randomized controlled trial
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria included:
(a) lower back pain persisting for 4 weeks or more;
(b) age 17–68 years; and
(c) current episode of low back pain having at least a 4-week duration. Exclusion criteria included possible spinal pathology (e.g., carcinoma), severe or progressive motor weakness or central disc prolapse, pending litigation (e.g., workplace injury), bleeding disorders (e.g., hemophilia), and current treatment with wet-cupping.
Age
From 17 years old to 68 years old
Gender
Both
Phase
3
Groups that have been masked
No information
Sample size
Target sample size:
98
Randomization (investigator's opinion)
Randomized
Randomization description
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
1
Registry name
Secondary trial Id
Registration date
2017-11-21, 1396/08/30
Ethics committees
1
Ethics committee
Name of ethics committee
Kermanshah University of Medical Sciences
Street address
Kermanshah, Iran
City
Kermanshah
Postal code
Approval date
2008-03-03, 1386/12/13
Ethics committee reference number
87009
Health conditions studied
1
Description of health condition studied
Low Back Pain
ICD-10 code
ICD-10 code description
Primary outcomes
1
Description
Low Back Pain
Timepoint
At baseline and 3 months following intervention
Method of measurement
the McGill Present Pain Index
Secondary outcomes
1
Description
Disability
Timepoint
At baseline and again 3 months following intervention
Method of measurement
Oswestry Pain Disability Index
2
Description
Medication
Timepoint
At baseline and again 3 months following intervention